nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

01.06.2012 | Original Paper

Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression

verfasst von: Isabella Helmreich, Stefanie Wagner, Roland Mergl, Antje-Kathrin Allgaier, Martin Hautzinger, Verena Henkel, Ulrich Hegerl, André Tadić

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

In the efficacy evaluation of antidepressant treatments, the total score of the Hamilton Depression Rating Scale (HAMD) is still regarded as the ‘gold standard’. We previously had shown that the Inventory of Depressive Symptomatology (IDS) was more sensitive to detect depressive symptom changes than the HAMD17 (Helmreich et al. 2011). Furthermore, studies suggest that the unidimensional subscales of the HAMD, which capture the core depressive symptoms, outperform the full HAMD regarding the detection of antidepressant treatment effects. The aim of the present study was to compare several unidimensional subscales of the HAMD and the IDS regarding their sensitivity to changes in depression symptoms in a sample of patients with mild major, minor or subsyndromal depression (MIND). Biweekly IDS-C28 and HAMD17 data from 287 patients of a 10-week randomised, placebo-controlled trial comparing the effectiveness of sertraline and cognitive–behavioural group therapy in patients with MIND were converted to subscale scores and analysed during the antidepressant treatment course. We investigated sensitivity to depressive change for all scales from assessment-to-assessment, in relation to depression severity level and placebo–verum differences. The subscales performed similarly during the treatment course, with slight advantages for some subscales in detecting treatment effects depending on the treatment modality and on the items included. Most changes in depressive symptomatology were detected by the IDS short scale, but regarding the effect sizes, it performed worse than most subscales. Unidimensional subscales are a time- and cost-saving option in judging drug therapy outcomes, especially in antidepressant treatment efficacy studies. However, subscales do not cover all facets of depression (e.g. atypical symptoms, sleep disturbances), which might be important for comprehensively understanding the nature of the disease depression. Therefore, the cost-to-benefit ratio must be carefully assessed in the decision for using unidimensional subscales.

Nur mit Berechtigung zugänglich

The mean baseline sum scores for the HAMD17 and the IDS-C28 differ slightly from the previously presented figures [29] due to differences in sample size.

American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington DC

Bagby M, Ryder AG, Schuller DR, Marshall MB (2004) The Hamilton depression rating scale: has the gold standard become a lead weight? Am J Psychiatry 161:2163–2177PubMedCrossRef

Ballesteros J, Bobes J, Bulbena A, Luque A, Dal-Ré R, Ibarra N, Güemes I (2007) Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD). J Affect Disord 102:93–99PubMedCrossRef

Bech P (2001) Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression. Int J Neuropsychopharmacol 4:337–345PubMedCrossRef

Bech P (2008) The use of rating scales in affective disorders. Eur Psychiatr Rev 1:14–18

Bech P (2010) Is the antidepressive effect of second-generation antidepressants a myth? Psychol Med 40:181–186PubMedCrossRef

Bech P, Gram LF, Dein E, Jacobsen O, Vitger J, Bolwig TG (1975) Quantitative rating of depressive states. Acta Psychiatr Scand 51:161–170PubMedCrossRef

Bech P, Rafaelsen OJ (1980) The use of rating scales exemplified by a comparison of the Hamilton and the Bech Rafaelsen Melancholia scale. Acta Psychiatr Scand 62(S285):128–131CrossRef

Bech P, Allerup P, Gram LF, Reisby N, Rosenberg R, Jacobsen O, Nagy A (1981) The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand 63:290–299PubMedCrossRef

10.

Bech P, Allerup P, Reisby N, Gram LF (1984) Assessment of symptom change from improvement curves on the Hamilton Depression Scale in trials with antidepressants. Psychopharmacology 84:276–281PubMedCrossRef

11.

Bech P, Ciadella P, Haugh MC, Hours A, Boissel JP, Birkett MA, Tolllefson GD (2000) Meta-analysis of randomised controlled trials of fluoxetine vs. placebo and tricyclic antidepressants in the short-term treatment of major depression. Br J Psychiatry 176:421–428PubMedCrossRef

12.

Bech P, Tanghoj P, Andersen HF, Overo K (2002) Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression. Psychopharmacology 163:20–25PubMedCrossRef

13.

Bech P, Boyer P, Germain JM, Padmanabhan K, Haudiquet V, Pitrosky B, Tourian KA (2010) HAM-D17 and HAM-D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder. Pharmacopsychiatry 43:271–276PubMedCrossRef

14.

Benazzi F (1998) A 10-item hamilton depression rating scale to measure major depressive episode severity in outpatients. Int J Geriatr Psych 13:568–574CrossRef

15.

Bent-Hansen J, Lunde M, Klysner R, Andersen M, Tanghøj P, Solstad K, Bech P (2003) The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry 36:313–316PubMedCrossRef

16.

Carmody TJ, Rush AJ, Bernstein I, Warden D, Brannan S, Burnham D, Woo A, Trivedi MH (2006) The Montgomery Åsberg and the Hamilton ratings of depression: a comparison of measures. Eur Neuropsychopharmacol 16:601–611PubMedCrossRef

17.

Coryell W, Endicott J, Andreasen NC, Keller MB, Clayton PJ, Hirschfield RM, Scheftner WA, Winokur G (1988) Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry 145:293–300PubMed

18.

Entsuah R, Shaffer M, Zhang J (2002) A critical examination of the sensitivity of unidimensional subscales derived from the Hamilton Depression Rating Scale to antidepressant drug effects. J Psychiatr Res 36:437–448PubMedCrossRef

19.

Evans KR, Sills T, DeBrota DJ, Gelwicks S, Engelhardt N, Santor D (2004) An item response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies. J Psychiatr Res 38:275–284PubMedCrossRef

20.

Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter WZ (2000) The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res 34:3–10PubMedCrossRef

21.

Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH (2008) Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 165:342–351PubMedCrossRef

22.

Gibbons RD, Clark DC, Kupfer DJ (1993) Exactly what does the Hamilton Depression Rating Scale measure? J Psychiatr Res 27:259–273PubMedCrossRef

23.

Hamilton M (1960) A rating scale for depression. J Neurology, Neurosurgery, Psychiatry 23:56–62CrossRef

24.

Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296PubMedCrossRef

25.

Hamilton M, Shapiro CM (1990) Depression. In: Peck DF, Shapiro CM (eds) Measuring human problems. Wiley, Chichester, pp 25–65

26.

Hecht H, von Zerssen D, Wittchen H-U (1990) Anxiety and depression in a community sample: the influence of comorbidity on social functioning. J Affect Disord 18:137–144PubMedCrossRef

27.

Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic Press, New York, pp 78–85

28.

Hegerl U, Hautzinger M, Mergl R, Kohnen R, Schütze M, Scheunemann W, Allgaier A-K, Coyne J, Henkel V (2010) Effects of pharmaco- and psychotherapy in depressed primary care patients. A randomized, controlled trial including a patient choice arm. Int J Neuropsychopharmacol 13:31–44PubMedCrossRef

29.

Helmreich I, Wagner S, Mergl R, Allgaier A-K, Hautzinger M, Henkel V, Hegerl U, Tadić A (2011) The Inventory of Depressive Symptomatology (IDS-C28) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD17) in patients with mild major, minor or subsyndromal depression. Eur Arch Psychiatry Clin Neurosci 261:357–367PubMedCrossRef

30.

Hooper CL, Bakish D (2000) An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder. J Psychiatry Neurosci 25:178–184PubMed

31.

Howland RH, Schettler PJ, Rapaport MH, Mischoulon D, Schneider T, Fasiczka A, Delrahiem K, Maddux R, Lightfoot M, Nierenberg AA (2008) Clinical features and functioning of patients with minor depression. Psychother Psychosom 77:384–389PubMedCrossRef

32.

Iannuzzo R, Jaeger J, Goldberg J, Kafantaris V, Subletteet M (2006) Development and reliability of the HAM-D/MADRS Interview: An integrated depression symptom rating scale. Psychiat Res 145:21–37CrossRef

33.

Ilardi SS, Craighead WE (1994) The role of nonspecific factors in cognitive-behavior therapy for depression. Clin Psychol Sci and Practice 1:138–156CrossRef

34.

Lecrubier Y, Bech P (2007) The Ham D(6) is more homogenous and as sensitive as the Ham D(17). Eur Psychiatry 22:252–255PubMedCrossRef

35.

Maier W (1990) The Hamilton Depression Scale and its alternatives: a comparison of their reliability and validity. In: Bech P, Coppen A (eds) The Hamilton Scales. Springer-Verlag, Berlin, pp 64–71

36.

Maier W, Heuser I, Philipp M, Frommberger U, Demuth W (1988) Improving depression severity assessment—II. Content, concurrent and external validity of three observer depression scales. J Psychiatr Res 22:13–19PubMedCrossRef

37.

Maier W, Philipp M (1985) Improving the assessment of severity of depressive states: a reduction of the Hamilton depression scale. Pharmacopsychiatry 18:114–115CrossRef

38.

Maier W, Philipp M, Heuser I, Schlegel S, Buller R, Wetzel H (1988) Improving depression severity assessment—I. Reliability, internal validity and sensitivity to change of three observer depression scales. J Psychiatr Res 22:3–12PubMedCrossRef

39.

McIntyre R, Kennedy S, Bagby RM, Bakish D (2002) Assessing full remission. J Psychiatry Neurosci 27:235–239PubMed

40.

McIntyre R, Konarski JZ, Mancini DA, Fulton KA, Parikh SV, Grigoriadis S, Grupp LA, Bakish D, Filteau M-J, Gorman C, Nemeroff CB, Kennedy SH (2005) Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ 173:1327–1334PubMedCrossRef

41.

Möller H-J (2001) Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale. Eur Arch Psychiatry Clin Neurosci 251(suppl 2):13–20CrossRef

42.

Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389PubMedCrossRef

43.

National Institute for Health, Clinical Excellence (2009) Depression: the Treatment and Management of Depression in Adults. National Clinical Practice Guideline 90. National Institute for Health and Clinical Excellence, London

44.

Nutt D (1997) Management of patients with depression associated with anxiety symptoms. J Clin Psychiatry 58(Suppl 8):11–16PubMed

45.

O’Sullivan RL, Fava M, Agustin C, Baer L, Rosenbaum JF (1997) Sensitivity of the six-item Hamilton depression rating scale. Acta Psychiatr Scand 95:379–384PubMedCrossRef

46.

Papakostas GI, Larsen K (2011) Testing anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopram. Eur Arch Psychiatry Clin Neurosci 261:147–156PubMedCrossRef

47.

Paykel ES (1990) The use of the Hamilton Depression Scale in general practice. In: Bech P, Coppen A (eds) The Hamilton Scales. Springer-Verlag, Berlin, pp 40–48

48.

Rapaport MH, Judd LL, Schettler PJ, Yonders KA, Thase ME, Kupfer DJ, Frank E, Plewes JM, Tollefson GD, Rush AJ (2002) A descriptive analysis of minor depression. Am J Psychiatry 159:637–643PubMedCrossRef

49.

Riedel M, Möller H-J, Obermeier M, Adli M, Bauer M, Kronmüller K, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Schennach-Wolff R, Henkel V, Seemüller F. (2011) Clinical predictors of response and remission in inpatients with depressive syndromes. J Affect Disord doi:10.1016/j.jad.2011.04.007

50.

Ruhé HG, Dekker JJ, Peen J, Holman R, de Jonghe F (2005) Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores. Comprehensive Psychiatry 46:417–427PubMedCrossRef

51.

Rush AJ, Bernstein IH, Trivedi MH, Carmody TJ, Wisniewski S, Mundt JC, Shores-Wilson K, Biggs MM, Woo A, Nierenberg AA, Fava M (2006) An Evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: A Sequenced Treatment Alternatives to Relieve Depression Trial Report. Biol Psychiatry 59:493–501PubMedCrossRef

52.

Rush AJ, Carmody TJ, Ibrahim HM, Trivedi HM, Biggs MM, Shores-Wilson K, Crismon ML, Toprac MG, Kashner TM (2006) Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. Psychiatr Serv 57:826–837CrossRef

53.

Rush AJ, Carmody TJ, Reimitz PE (2000) The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res 9:45–59CrossRef

54.

Rush AJ, Gilles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C (1986) The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 18:65–87PubMedCrossRef

55.

Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi HM (1996) The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 26:477–486PubMedCrossRef

56.

Santen G, Danhof M, Pasqua OD (2009) Sensitivity of the Montgomery Asberg Depression Rating Scale to response and its consequences for the assessment of efficacy. J Psychiatr Res 43:1049–1056PubMedCrossRef

57.

Santen G, Gomeni R, Danhof M, Pasqua OD (2008) Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy. J Psychiatr Res 42:1000–1009PubMedCrossRef

58.

Senra C, Polaino A (1993) Concordance between clinical and self-report depression scales during the acute phase and after treatment. J Affect Disord 27:13–19PubMedCrossRef

59.

Silverstone PH, Entsuah R, Hackett D (2002) Two items on the Hamilton Depression rating scale are elective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine. Int Clin Psychopharmacol 17:273–280PubMedCrossRef

60.

Trivedi MH (2009) Tools and strategies for ongoing assessment of depression: a measurement-based approach to remission. J Clin Psychiatry 70(Suppl 6):26–31PubMedCrossRef

61.

Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM (2004) The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self Report (IDS-SR) and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 34:73–82PubMedCrossRef

62.

Vittengl JR, Clark LA, Kraft D, Jarrett R (2005) Multiple measures, methods, and moments: a factor-analytic investigation of change in depressive symptoms during acute-phase cognitive therapy for depression. Psychol Med 35:693–704PubMedCrossRef

63.

Walczak DD, Apter JT, Halikas JA, Borison RL, Carman JS, Post GL, Patrick R, Cohn JB, Cunningham LA, Rittberg B, Preskorn SH, Kang JS, Wilcox CS (1996) The oral dose-effect relationship for fluvoxamine: a fixed-dose comparison against placebo in depressed outpatients. Ann Clin Psychiatry 8:139–151PubMedCrossRef

64.

Wittchen H-U, Pfister H (eds) (1997) DIA-X-Interview, Instruktionsmanual zur Durchführung von DIA-X Interviews. Swets & Zeitlinger, Frankfurt am Main

65.

WorldHealth Organization (WHO) (1993) Composite International Diagnostic Interview, Version 1.1. World Health Organization, Geneva

66.

Yang H, Chuzi S, Sinicropi-Yao L, Johnson D, Chen Y, Clain A, Baer L, McGrath PJ, Stewart JW, Fava M, Papakostas GI (2010) Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine. Eur Arch Psychiatry Clin Neurosci 260:145–150PubMedCrossRef

67.

Zimmerman M, Posternak MA, Marshall MB (2005) Is it time to replace the Hamilton Depression Rating Scale as the primary outcome measure in treatment studies of depression? J Clin Psychopharmacol 25:105–110PubMedCrossRef

Titel: Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression
verfasst von: Isabella Helmreich
Stefanie Wagner
Roland Mergl
Antje-Kathrin Allgaier
Martin Hautzinger
Verena Henkel
Ulrich Hegerl
André Tadić
Publikationsdatum: 01.06.2012
Verlag: Springer-Verlag
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 4/2012
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-011-0263-x

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

Longitudinal changes of fractional anisotropy in Alzheimer’s disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study

Correlation with statistical significance and its explanation rate: comment on Minelli et al., “BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects.” (Eur Arch Psychiatry Clin Neurosci doi:10.1007/s00406-011-0189-3)

Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder

From pathophysiological aspects towards unravelling the neurobiological background of cognitive deficits